نتایج جستجو برای: voriconazole

تعداد نتایج: 2934  

Journal: :International Journal of Hematology 2008
Jörg J. Vehreschild Angelika Böhme Dietmar Reichert Michael G. Kiehl Dorothee Arenz Karen Pankraz Matthias Kochanek Andrew J. Ullmann Oliver A. Cornely

Invasive fungal infections are frequent and often deadly complications in patients with malignant hematological diseases. Voriconazole is a third generation triazole antifungal with broad activity against most clinically relevant fungal pathogens. Clinical practice often deviates from insights gained from controlled randomized trials. We conducted a multi-centre survey to evaluate efficacy, saf...

Journal: :Journal of clinical microbiology 2006
Anil A Panackal Jennifer L Gribskov Janet F Staab Katherine A Kirby Michael Rinaldi Kieren A Marr

Candida glabrata, which can become resistant to fluconazole, is a common cause of bloodstream infection. This study was performed to determine the significance of cross-resistance to new azole drugs among C. glabrata isolates recovered as a cause of infection in azole-treated hematopoietic stem cell transplant (HSCT) recipients. Seven cases of invasive candidiasis caused by C. glabrata occurred...

Journal: :Haematologica 2012
Géraldine Salmeron Raphaël Porcher Anne Bergeron Marie Robin Régis Peffault de Latour Christèle Ferry Vanderson Rocha Anna Petropoulou Aliénor Xhaard Claire Lacroix Annie Sulahian Gérard Socié Patricia Ribaud

BACKGROUND Voriconazole treatment increases early survival of allogeneic hematopoietic stem cell transplant recipients with invasive aspergillosis. We investigated whether this survival advantage translates into an increased long-term survival. DESIGN AND METHODS This retrospective study involved all patients with an invasive aspergillosis diagnosis transplanted between September 1997 and Dec...

Journal: :Reactions Weekly 2022

2012
Bernhard Gerber Roman Guggenberger David Fasler Gayathri Nair Markus G. Manz Georg Stussi Urs Schanz

We here investigate the occurrence of fluoride intake-associated alterations in patients with hematologic disease on triazol antifungal medication. Clinical, laboratory, and radiology data of overall 43 patients with hematologic malignancies taking voriconazole (n 20), posaconazole (n 8), and itraconazole (n 4), and a hematologic patient control group (n 11) are described. Bone pain and radiolo...

Journal: :Cornea 2010
Elmer Y Tu Charlotte E Joslin Megan E Shoff

PURPOSE To describe the treatment of chronic stromal Acanthamoeba keratitis (AK) with oral voriconazole monotherapy. METHODS All cases of chronic stromal AK recalcitrant to traditional therapy subsequently treated with systemic voriconazole seen at the University of Illinois Eye and Ear Infirmary between June 2003 and July 2009 were reviewed for clinical presentation, clinical course, and out...

2013
Wilfried Rozhon Sigrid Husar Florian Kalaivanan Mamoona Khan Markus Idlhammer Daria Shumilina Theo Lange Thomas Hoffmann Wilfried Schwab Shozo Fujioka Brigitte Poppenberger

Brassinosteroids (BRs) are plant steroid hormones with structural similarity to mammalian sex steroids and ecdysteroids from insects. The BRs are synthesized from sterols and are essential regulators of cell division, cell elongation and cell differentiation. In this work we show that voriconazole, an antifungal therapeutic drug used in human and veterinary medicine, severely impairs plant grow...

Journal: :Reactions Weekly 2021

Journal: :Journal of the American Academy of Dermatology 2010
Edward W Cowen Josephine C Nguyen Daniel D Miller Diana McShane Sarah T Arron Neil S Prose Maria L Turner Lindy P Fox

BACKGROUND Voriconazole is a broad-spectrum antifungal agent associated with photosensitivity and accelerated photoaging. A possible link with aggressive squamous cell carcinoma (SCC) has also been reported. OBJECTIVE We sought to determine the incidence and frequency of cutaneous SCC among patients undergoing long-term treatment with voriconazole who also manifest features of chronic phototo...

Journal: :Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2010
Michael Neely Teresa Rushing Andrea Kovacs Roger Jelliffe Jill Hoffman

BACKGROUND Voriconazole pharmacokinetic and pharmacodynamic data are lacking in children. METHODS Records at the Childrens Hospital Los Angeles were reviewed for children with > or =1 serum voriconazole concentration measured from 1 May 2006 through 1 June 2007. Information on demographic characteristics, dosing histories, serum concentrations, toxicity and survival, and outcomes was obtained...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید